NFKB1 and irritable bowel syndrome: In addition to probiotics, MT is also closely linked to the gut microbiota, mitigated colonic microbiota dysbiosis, and intestinal inflammation in IBS animal models by inhibiting the activation of the TLR4/NF-κB pathway (49).